IPO registrations (S-1, F-1) · Registrants

T2 Biosystems, Inc.

SEC CIK
1492674 · filings on EDGAR ↗
Registration
Form S-1, first filed 2014-07-02, last 2024-05-06; 2 initial registrations, 4 amendments
Outcome
Final prospectus filed 2014-08-07; declared effective 2014-08-06; withdrawal requested 2024-05-14
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
101 HARTWELL AVENUE, Lexington, MA 02421
EIN
20-4827488
EDGAR entity type
operating
Insiders and CEO pay
T2 Biosystems, Inc. on the corporate pages

Offering terms

Proposed price range
$15.00–$17.00 per share (S-1/A filed 2014-07-28)
Final price
$11.00 per share, below the range (424B4 filed 2014-08-07, an initial public offering)
Shares sold
5,200,000
Gross proceeds
$57,200,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TTOO
Lead underwriters
Goldman Sachs (2,080,000 shares); Morgan Stanley (2,080,000 shares)
Syndicate
Leerink Partners (728,000); Janney Montgomery Scott (312,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 17

FiledFormWhat it isName as filedEDGAR
2014-07-02S-1S-1 (registration)T2 Biosystems, Inc.0001047469-14-005988 ↗
2014-07-16S-1/AS-1/A (amendment)T2 Biosystems, Inc.0001047469-14-006215 ↗
2014-07-28S-1/AS-1/A (amendment)T2 Biosystems, Inc.0001047469-14-006416 ↗
2014-08-06S-1MEFS-1MEF (added securities)T2 Biosystems, Inc.0001104659-14-057771 ↗
2014-08-06EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-14-002407 ↗
2014-08-07424B4424B4 (final prospectus)T2 Biosystems, Inc.0001047469-14-006761 ↗
2015-09-22EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-15-002566 ↗
2017-05-05EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-17-001197 ↗
2018-10-24EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-18-002710 ↗
2021-04-09EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-21-001381 ↗
2023-09-15EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-23-002675 ↗
2024-04-22S-1S-1 (registration)T2 Biosystems, Inc.0001193125-24-105041 ↗
2024-05-06S-1/AS-1/A (amendment)T2 Biosystems, Inc.0001193125-24-131474 ↗
2024-05-06S-1/AS-1/A (amendment)T2 Biosystems, Inc.0001193125-24-132063 ↗
2024-05-14RWRW (withdrawal request)T2 Biosystems, Inc.0001193125-24-138338 ↗
2024-06-04EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-24-001744 ↗
2024-07-29EFFECTEFFECT (declared effective)T2 Biosystems, Inc.9999999995-24-002305 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-07-28S-1/Aregistration statement$15.00–$17.004,000,000-Nasdaq TTOO4primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4document ↗
2014-08-07424B4final prospectus$11.005,200,000$57,200,000Nasdaq TTOO4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
AFEYAN NOUBARTenPercentOwner22014
AISLING CAPITAL III LPTenPercentOwner32014–2015
Aisling Capital Partners III LLCTenPercentOwner32014–2015
Aisling Capital Partners III LPTenPercentOwner32014–2015
Bilenker Joshua H.Director32014–2016
Bridge Street 2013 Holdings, L.P.TenPercentOwner32014–2015
Bridge Street 2013, L.P.TenPercentOwner32014–2015
Bridge Street 2013 Offshore, L.P.TenPercentOwner32014–2015
Bridge Street Opportunity Advisors, L.L.C.TenPercentOwner32014–2015
Broad Street Principal Investments, L.L.C.TenPercentOwner32014–2015
CARELLA THOMAS J.Director42014–2015
Cima Michael J.Director132014–2019
Crane Alan LDirector22014
CUMMING JOHN WDirector152014–2025person page Fuzzy
ELMS STEVEDirector,TenPercentOwner; TenPercentOwner32014–2015
Elsbree David BDirector302014–2025person page Fuzzy
Flagship Ventures Fund 2004 L PTenPercentOwner22014
Flagship Ventures Fund IV General Partner LLCTenPercentOwner22014
Flagship Ventures Fund IV, L.P.TenPercentOwner22014
Flagship Ventures General Partner LLCTenPercentOwner22014
GOLDMAN SACHS & COTenPercentOwner102014–2021
GOLDMAN SACHS GROUP INCTenPercentOwner102014–2021
Jones Marc R.OfficerChief Financial Officer12014
Kalil Sarah O.OfficerChief Operating Officer62014–2016
KANIA EDWIN M JRTenPercentOwner22014
LAPIDUS STANLEY NDirector22014–2015
Lowery Thomas J.OfficerChief Scientific Officer302014–2020
MBD 2013 Holdings, L.P.TenPercentOwner32014–2015
MBD 2013, L.P.TenPercentOwner32014–2015
MBD 2013 Offshore, L.P.TenPercentOwner32014–2015
MBD Advisors, L.L.C.TenPercentOwner32014–2015
McDonough JohnDirector; Director,OfficerPresident and CEO; President & CEO212014–2021
Pfaller Michael A.OfficerChief Medical Officer32014–2016
Polaris Venture Management Co. V, L.L.C.TenPercentOwner122014–2015
Polaris Venture Partners Entrepreneurs' Fund V, L.P.TenPercentOwner122014–2015
Polaris Venture Partners Founders' Fund V, L.P.TenPercentOwner122014–2015
Polaris Venture Partners Special Founders' Fund V, L.P.TenPercentOwner122014–2015
Polaris Venture Partners V, L.P.TenPercentOwner122014–2015
Purcell Dennis JTenPercentOwner32014–2015
SCHIFF ANDREW NTenPercentOwner32014–2015
WILCOX HARRY WDirector32014–2016
CASTONGUAY MAURICE LOfficerChief Financial Officer22015
Harding DavidOfficerChief Commercial Officer32015–2017
Gibbs Michael TerrenceOfficerGeneral Counsel342016–2025
Dhanda RahulOfficerSVP of Corporate Development82016–2017
Jones Adrian MDirector92016–2021person page Fuzzy
Lynch ShawnOfficerChief Financial Officer32016–2017
Lapidus StanleyDirector82016–2019
Spadoro JoanneOfficerChief Operations Officer42016–2017
LIEBMAN SEYMOURDirector172016–2025
CANON INCTenPercentOwner12016
CANON U.S.A., INC.TenPercentOwner12016
DEPTULA-HICKS DARLENE MOfficerChief Financial Officer; SVP & Chief Financial Officer32017
Sprague John MOfficerCFO; Chief Financial Officer192018–2025
Barclay AlecOfficerChief Operations Officer; See Remarks; SVP, Operations182018–2022
Sperzel John J IIIDirector,OfficerChairman and CEO; Chairman, CEO, and President; President and CEO; See Remarks102020–2025
Pare AnthonyOfficerChief Commercial Officer52020–2021
Bernard ThierryDirector112020–2023
Saunders NinfaDirector122020–2025
Toft RobinDirector132020–2025
Ahuja AparnaOfficerChief Medical Officer52021–2022
Adams Laura LeeDirector62021–2025
Giffin Brett A.OfficerChief Commercial Officer112021–2025
CRG Partners III (Cayman) Lev AIV I L.P.TenPercentOwner142023–2024
CRG Partners III (Cayman) Unlev AIV I L.P.TenPercentOwner142023–2024
CRG Partners III L.P.TenPercentOwner142023–2024
CRG Partners III - Parallel Fund (A) L.P.TenPercentOwner142023–2024
CR Group L.P.TenPercentOwner142023–2024
CRG Partners III - Parallel Fund B (Cayman) L.P.TenPercentOwner52023–2024

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-09-27T2 Biosystems, Inc.Other Health Care$39,723,037$39,723,03711

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationT2 Biosystems, IncMAState business registriesname and state
Business registrationT2 Biosystems, Inc.MAState business registriesname and state
Business registrationT2 Biosystems, Inc.MAState business registriesname and state
Business registrationT2 BIOSYSTEMS, INC.MAState business registriesname and state
Business registrationT2 BIOSYSTEMS, INC.MAState business registriesname and state
Business registrationT2 BIOSYSTEMS, INC.MAState business registriesname and state
Business registrationT2 BIOSYSTEMS, INC.MAState business registriesname and state
Plan sponsorT2 BIOSYSTEMSMAForm 5500 (employee benefit plans)name and state
Plan sponsorT2 BIOSYSTEMS, INCMAForm 5500 (employee benefit plans)name and state
Federal award recipientT2 BIOSYSTEMS, INCMAFederal spending (USAspending)name and state
Form D issuerT2 Biosystems, Inc.MAForm D private offeringsCIK (EXACT)
Lobbying clientT2 BIOSYSTEMSMAFederal lobbying (LDA)name and state
Lobbying clientT2 BIOSYSTEMS, INC.MAFederal lobbying (LDA)name and state
Paying companyT2 Biosystems, Inc.MAOpen Payments (drug and device company payments)name and state
Patent assigneeT2 Biosystems, Inc.MAPatents (USPTO)name and state
SEC filerT2 Biosystems, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerT2 Biosystems, Inc.MATrademarks (USPTO)name and state
Form 5500 plan sponsorT2 BIOSYSTEMS, INCEIN (EXACT)
Person pageAdrian M JonesPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageDavid B ElsbreePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageJohn W CummingPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, MA first:

More with this interest.

In other datasets, the same topic (Technology) in MA:

Interests: Surgical & Medical Instruments & Apparatus · Technology